top of page
Search
Writer's pictureManya kaur

United States Assisted Reproductive Technology Market is Expected to Grow at a CAGR of 7.10% by 2032

United States Assisted Reproductive Technology Market Overview


Base Year: 2023

Historical Years: 2018-2023

Forecast Years: 2024-2032

Market Growth Rate: 7.10% (2024-2032)


The United States assisted reproductive technology market is experiencing robust growth, driven by several key factors and emerging trends. According to the latest report by IMARC Group, the market size is projected to exhibit a growth rate (CAGR) of 7.10% during 2024-2032.


Assisted Reproductive Technology (ART) encompasses medical procedures and techniques used to aid individuals or couples in achieving pregnancy. It primarily includes in vitro fertilization (IVF), intrauterine insemination (IUI), and intracytoplasmic sperm injection (ICSI). ART procedures often begin with the stimulation of a woman’s ovaries to produce multiple eggs, which are then retrieved and fertilized with sperm in a laboratory setting. The fertilized eggs, or embryos, are subsequently transferred to the woman’s uterus with the aim of establishing a successful pregnancy. These procedures are utilized not only by couples facing infertility issues but also by single individuals and same-sex couples seeking to have children. ART is an evolving field, constantly benefiting from advancements in medical science and technology, including the use of preimplantation genetic testing to screen embryos for genetic conditions, thereby increasing the chances of a healthy pregnancy.





For an in-depth analysis, you can refer sample copy of the report: https://www.imarcgroup.com/united-states-assisted-reproductive-technology-market/requestsample


United States Assisted Reproductive Technology Industry Trends and Drivers:


The United States Assisted Reproductive Technology (ART) market is rapidly expanding due to several key factors and emerging trends. The increasing prevalence of infertility, influenced by delayed childbearing, lifestyle changes, and underlying medical conditions, is a primary driver of this growth. As more individuals and couples encounter challenges in conceiving naturally, the demand for ART services has significantly increased. Furthermore, greater societal acceptance and awareness of ART are encouraging more people to pursue these treatments. Advances in medical technology and techniques, such as more efficient ovarian stimulation protocols, improved embryo culture conditions, and sophisticated genetic screening methods, have notably improved the success rates of ART procedures, fueling market growth. Additionally, the trend of elective single embryo transfers (eSET) to minimize the risk of multiple pregnancies and associated complications signifies a shift towards safer and more personalized fertility treatments. Government initiatives expanded insurance coverage, supportive legal frameworks for donor gametes and surrogacy arrangements, and the integration of advanced technologies like artificial intelligence (AI) and machine learning in fertility clinics are further propelling the market expansion. Ongoing research and development activities focused on enhancing ART techniques and outcomes are expected to contribute to continued United States assisted reproductive technology market growth.


United States Assisted Reproductive Technology Industry Segmentation:


The report has segmented the market into the following categories:


Product Insights:


  • Instrument

  • Sperm Separation System

  • Cryosystem

  • Incubator

  • Imaging System

  • Ovum Aspiration Pump

  • Cabinet

  • Micromanipulator

  • Laser Systems

  • Others

  • Accessory and Disposable

  • Reagents and Media

  • Cryopreservation Media

  • Semen Processing Media

  • Ovum Processing Media

  • Embryo Culture Media

Type Insights:


  • In-Vitro Fertilization (IVF)

  • Fresh Donor

  • Frozen Donor

  • Fresh Non-Donor

  • Frozen Non-Donor

  • Artificial Insemination

  • Intrauterine Insemination

  • Intracervical Insemination

  • Intravaginal Insemination

  • Intratubal Insemination


End Use Insights:


  • Fertility Clinics and Other Facilities

  • Hospitals and Others


Regional Insights:


  • Northeast

  • Midwest

  • South

  • West


Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players.


Ask Our Expert & Browse Full Report with TOC & List of Figure: https://www.imarcgroup.com/request?type=report&id=20291&flag=C


Key highlights of the Report:


  • Market Performance (2018-2023)

  • Market Outlook (2024-2032)

  • COVID-19 Impact on the Market

  • Porter’s Five Forces Analysis

  • Strategic Recommendations

  • Historical, Current and Future Market Trends

  • Market Drivers and Success Factors

  • SWOT Analysis

  • Structure of the Market

  • Value Chain Analysis

  • Comprehensive Mapping of the Competitive Landscape


Note: If you need specific information that is not currently within the scope of the report, we can provide it to you as a part of the customization.


About Us:


IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.


IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.


Contact Us:  

IMARC Group 

134 N 4th St. Brooklyn, NY 11249, USA 

Tel No:(D) +91 120 433 0800 

United States: +1-631-791-1145

 

 

 

 

 

1 view0 comments

Comments


bottom of page